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The intermediate filament protein vimentin was phosphorylated with CAMP-dependent protein kinase under conditions 
that induce filament disassembly. Digestion of phosphorylated vimentin with lysine-specific endoprotease and subsequent 
tryptic peptide mapping indicated that a 12 kDa N-terminal fragment contained all the phosphorylation sites found in 
the intact molecule Analysis of cyanogen bromide digests indicated that two phosphorylated peptides were produced, 
with the major 32P-labeled species representing amino acid position 14-72, and a minor 32P-labeled peptide representing 
amino acid positions l-13. These results demonstrate that phosphorylation of sites within the N-terminal head domain 
of vimentin are associated with phosphorylation induced filament disassembly. 
Intermediate filament; Phosphorylation; CAMP-dependent kinase 
1. INTRODUCTION 
The intermediate filament protein vimentin is 
one of the most prominent cellular phosphopro- 
teins in animal cells of mesenchymal origin [l-3]. 
The precise effect of phosphorylation on in- 
termediate filaments in intact cells is unknown. 
However, the phosphate turns over more rapidly 
than the protein itself [ 1,4-51, and there are tem- 
poral associations between increased vimentin 
phosphorylation and alterations in filament 
organization [6-91. These observations have led to 
speculation that phosphorylation plays an impor- 
tant role in regulating the organization of the 
intermediate filament component of the 
cytoskeleton. 
Vimentin contains structural domains that are 
characteristic of all non-epithelial intermediate 
filament proteins [ 10,111. A central cu-helical ‘rod’ 
domain is flanked by non-a-helical terminal do- 
mains [ 10-121. The central domain appears to be 
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required for maintaining the coiled-coil interac- 
tions between subunit proteins. Based on sensitivi- 
ty to specific proteolysis, the N-terminal ‘head’ 
and C-terminal ‘tail’ domains appear to be located 
at the periphery of filaments [ 14-161. The N- 
terminal domain appears to be required for fila- 
ment assembly, but may not be required to main- 
tain assembled filaments [ 16-191. The C-terminal 
domain does not appear to be required for the 
assembly of intermediate filaments [17]. Although 
the functional significance of these terminal do- 
mains remains speculative, a number of in vitro in- 
teractions with specific molecules have been 
reported [ 18-241. 
Vimentin is a substrate in vivo [25-271 as well as 
in vitro [28] for CAMP-dependent protein kinases. 
Recently Inagaki et al. [29] reported that in vitro 
phosphorylation of vimentin filaments with 
CAMP-dependent kinase resulted in filament 
disassembly, while phosphorylation with C-type 
kinase had no effect on filaments. Peptide map- 
ping studies indicated that this phosphorylation- 
induced filament disassembly was site specific [29]. 
The present studies were conducted to determine 
if modification of specific structural regions of 
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vimentin are involved in phosphorylation specific 
filament disassembly. These studies indicate that 
the sites of vimentin phosphorylation by the 
catalytic subunit of CAMP-dependent kinase are 
within the N-terminal or head domain of the 
molecule. 
2. MATERIALS AND METHODS 
2.1. Cell culture 
Hamster BHK-21 cells were maintained in a monolayer 
culture in a 1 : 1 mixture of F-12/Dulbecco’s modified essential 
medium supplemented with 5% fetal bovine serum. 
2.2. Purification of vimentin 
BHK-21 cell vimentin was purified from Triton-insoluble 
cytoskeletons made essentially as described by Zackroff and 
Goldman [30]. The Triton-insoluble proteins were then 
separated on SDS-polyacrylamide gels [3 11. Following elec- 
trophoresis the gels were stained and destained as .previously 
described [32]. The stained vimentin band was excised from the 
gel and eluted in a solution containing 0.1% SDS, 0.05 M am- 
monium bicarbonate. The eluted protein was precipitated in 
9 vols of acetone/ammonium hydroxide 5 : 0.1 (v/v) at - 20°C 
for 30 min. The precipitated protein was recovered by cen- 
trifugation at 10000 x g for 30 min. The precipitate was dried 
under vacuum and then resuspended in 5 mM Tris-HC], pH 
8.8. Filaments were assembled in vitro by dialysis against 0.1 M 
NaCI, 30 mM Tris-HCI, pH 7.0. Insoluble vimentin filaments 
were collected by centrifugation at 12000 x g. 
2.3. In vitro phosphorylation 
CAMP-dependent protein kinase was purified from bovine 
heart as described by Beavo et al. [33]. The catalytic subunit 
was then dissociated and purified by the method of Bechtel et 
al. [34]. [y-“P]ATP was produced according to Johnson and 
Walseth [35] from carrier free [32P]phosphoric acid. Purified 
vimentin was phosphorylated essentially under conditions 
described by Inagaki et al. [29]. A solution containing 5 pM 
vimentin, 3.5 pg/ml catalytic subunit of CAMP-dependent pro- 
tein kinase, 0.05 mM ATP (200 pCi [y-‘*P]ATP), 30 mM Tris- 
HCI, pH 7.0, 120 mM NaCl and 1 mM MgCl2, was incubated 
for 30 min at 25°C. An equal volume of SDS sample buffer was 
then added and the “P-labeled vimentin repurified by SDS gel 
electrophoresis as described above. 
2.4. Filament disassembly 
Purified vimentin was assembled in vitro as described above. 
Insoluble filaments were rinsed in 120 mM NaCl, 30 mM Tris- 
HCl, pH 7.0, and centrifuged at 3000 x g for 5 min. Approx. 
15 pg of insoluble vimentin was resuspended in a total volume 
of 50~1 for phosphorylation with the catalytic subunit as 
described in the previous section. In some experiments, 
900 cpm of %-labeled vimentin was phosphorylated with 
unlabeled ATP. At various times after the addition of kinase, 
the reaction mixture was centrifuged at 12000 x g for 2 min and 
the supernatant recovered for SDS gel analysis. Following elec- 
trophoresis, the gels were stained, destained and the vimentin 
band excised. The gel pieces were rinsed in water and then in- 
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cubated in 1 M sodium salicylate for 20 min. ‘?S Radioactivity 
of gel pieces was determined in 4 ml scintillation fluid. 
2.5. Lysine-specific endoprotease and V-8 protease digestion 
Purified “P-labeled vimentin was resuspended in 50 pl of a 
solution containing 0.05% SDS, 0.05 M ammonium bicar- 
bonate, pH 8.0. 0.3 U of lysine-specific endoprotease 
(Calbiochem) in 10 pl of the same buffer was added. The diges- 
tion was carried out for 4 h at 37°C. An additional 0.15 U of 
lysine-specific protease was added, and the mixture incubated 
for 4-5 more h at 37°C. 
2.6. Tryptic phosphopeptide mapping 
32P-labeled vimentin nor N-terminal peptide were digested 
with trypsin and the resulting phosphopeptides were analyzed 
on thin layer cellulose by the method of O’Connor [36] as 
previously described [37]. 
2.1. Cyanogen bromide cleavage of the N-terminal peptide 
For the isolation of vimentin and the 12 kDa N-terminal pep- 
tide for cyanogen bromide cleavage, all gel electrophoresis was 
conducted as described above except with the addition of 
0.5 mM thioglycolic acid to the cathode running buffer. The 
12 kDa N-terminal peptide of vimentin, produced following 
lysine-specific protease digestion as described above, was iden- 
tified in unstained gels by autoradiography and excised from 
the gel using the autoradiograph as a guide. The peptide was 
eluted from the gel, acetone precipitated and dried under 
vacuum. Approx. 50 pg of purified peptide was resuspended in 
200 ,ul of 70% formic acid containing 2OOpg cyanogen 
bromide. The sample was incubated under nitrogen at 4°C for 
24 h, dried under nitrogen, resuspended in 50 pl of water and 
lyophilized. Peptides were resuspended in 0.1% trifluoroacetic 
acid (TFA) and separated by reversed-phase chromatography 
on a 4.6 mm x 12.5 cm Whatman Partisphere Cs column 
(Whatman). All analyses were performed with a Gilson gradient 
HPLC system (Gilson Medical Electronics). The column was 
run at room temperature with a flow rate of 1 ml/min. Samples 
were applied to the column and run in aqueous 0.1% TFA, 10% 
acetonitrile for 2 min. Retained material was eluted with a 
linear gradient of lo-80% acetonitrile, 0.1% TFA for 50 min. 
0.5 ml fractions were collected and “P radioactivity determined 
by Cerenkov counting. 
2.8. Amino acid analysis 
Peptides from reversed-phase HPLC were dried under 
nitrogen and then hydrolyzed in vacua at 105°C in constant 
boiling HCI. The acid was then removed under vacuum and the 
amino acids analyzed as the phenylthiocarbamyl (PTC) 
derivatives. Derivatization with phenylisothiocyanate and 
reversed-phase HPLC of the PTC-amino acids was carried out 
as by the method of Heinrikson and Meridith [38] as previously 
described [39]. 
3. RESULTS 
As previously reported by other investigators, 
vimentin is an in vitro substrate for CAMP- 
dependent protein kinases [28,29]. SDS gel 
analysis of the phosphorylation mixture after 
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Fig. 1. Phosphorylation-induced vimentin filament disassembly. 
Purified vimentin filaments were assembled in vitro and 
phosphorylated with the catalytic subunit of CAMP-dependent 
protein kinase as described in section 2. (A) ‘*P-autoradiograph 
of SDS gel of the phosphorylation reaction with time. The 
position of vimentin is indicated (V). (B) “S-autoradiograph of 
SDS gel electrophoresis of soluble vimentin released with time 
in the presence of kinase and ATP. Gel lanes O-9 correspond 
to 3 min intervals between 0 and 27 min. (C) The vimentin 
bands were excised from gels as shown in A and B and 
radioactivity determined to indicate the release of soluble 
vimentin with time of phosphorylation. Individual points 
represent the average of triplicate experiments. 
30 min indicated that vimentin was the major 
phosphorylated protein (fig. 1A). Similar ex- 
35 periments with S- labeled filamentous vimentin 
indicated a time-dependent release of soluble 
vimentin in the presence of catalytic subunit and 
ATP (fig. 1B). Incubations in the absence of kinase 
or ATP failed to produce soluble vimentin (not 
shown). A comparison of the time course for 
vimentin phosphorylation and the release of solu- 
ble vimentin (fig.lC) indicates that both 
phosphorylation and filament disassembly ap- 
proach maximal values within 30 min. To deter- 
mine if a specific region of vimentin was 
phosphorylated under disassembly conditions, 32P- 
labeled vimentin was eluted from SDS gels and 
treated with lysine-specific endoprotease. Diges- 
tion with lysine-specific protease produces a 
12 kDa N-terminal fragment which represents the 
N-terminal 93 amino acids and a number of 
smaller fragments from the remainder of the 
molecule [ 131. The identity of this fragment has 
been verified by amino acid analysis [39]. SDS gel 
analysis of the fragments produced by this diges- 
tion indicated that the predominant phos- 
phorylated peptide was the 12 kDa N-terminal 
peptide (fig.2). 
Tryptic phosphopeptide mapping studies have 
indicated that vimentin is phosphorylated at multi- 
ple serine sites [36,37,41]. To demonstrate that 
essentially all the phosphorylation that occurs in 
the intact molecule is localized in the 12 kDa N- 
terminal fragment, tryptic phosphopeptide map- 
ping studies were carried out on vimentin and the 
N-terminal peptide. As shown in fig.3, the pattern 
of multiple tryptic phosphopeptides produced 
from intact vimentin and the N-terminal peptide 
are virtually identical. 
The 12 kDa N-terminal peptide contains the en- 
tire N-terminal or head domain of hamster vimen- 
tin, which represents amino acid positions l-71, 
plus the first 24 amino acids of the a-helical rod 
domain [13,40]. To determine if the sites of 
phosphorylation were exclusively within the N- 
terminal domain, cyanogen bromide fragments of 
the 12 kDa peptide were prepared. The N-terminal 
peptide contains methionine at positions 13 and 72 
[40]. Consequently, 2 of the 3 resulting cyanogen 
bromide peptides represent the complete N- 
terminal domain. Reversed-phase HPLC analysis 
of cyanogen bromide-digested 12 kDa N-terminal 
peptide revealed two distinct 32P-labeled species, 
designated in order of elution CNBr 1 and 2 
(fig.4). The major 32P-labeled species, CNBr 2, 
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Fig.2. Lysine-specific protease digestion of vimentin 
phosphorylated by the catalytic subunit of CAMP-dependent 
kinase. Vimentin was repurified following in vitro phos- 
phorylation, digested with lysine-specific protease, and 
analyzed on a 15% SDS gel. (A) Protein stain, (B) ‘*P- 
autoradiograph. Gel lanes: (1) 15 pg undigested vimentin, (2) 
15 pg unphosphorylated vimentin plus protease, (3) 15 pg 
phosphorylated vimentin plus protease, (4) protease only, (5) 
protein standards: ovalbumin, 43 kDa; chymotrypsinogen, 
25.7 kDa; lactoglobulin, 18.4 kDa; lysozyme, 14.3 kDa; 
trypsin inhibitor, 6.2 kDa; and insulin A and B chains, 
2.3-3.4 kDa (unresolved). 
migrates as a 7 kDa peptide in SDS gel elec- 
trophoresis (fig.5) and the amino acid composition 
is consistent with this peptide representing amino 
acid positions 14-72. The minor 32P-labeled pep- 
tide, CNBr 1, was too small to be resolved on SDS 
gels, but amino acid analysis revealed that the pep- 
tide contained serine, homoserine, threonine, 
arginine and tyrosine, indicating that it is the N- 
terminal 13 amino acids of vimentin. These results 
indicate that all detectable phosphorylation occur- 
red within the N-terminal 72 amino acids, or 
within the N-terminal ‘head’ domain. 
4. DISCUSSION 
These experiments agree with the observation of 
Inagaki et al. [29] that phosphorylation of vimen- 
Fig.3. Phosphotryptic peptide analysis of phosphorylated 
vimentin and the 12 kDa N-terminal peptide. Electrophoresis at 
pH 1.9 was performed in the first dimension followed by 
ascending chromatography in the second dimension. (A) 
Vimentin, (B) 12 kDa N-terminal peptide, (C) mix of 
phosphopeptides from A and B. Origins are denoted 0. 
tin filaments with CAMP-dependent kinase results 
in filament disassembly and demonstrate that this 
phosphorylation occurs exclusively in the N- 
terminal ‘head’ domain of the molecule. Together, 
these observations indicate that modification of 
0 20 40 60 60 100 
Fraction Number 
Fig.4. Cyanogen bromide cleavage of “P-labeled 12 kDa N- 
terminal peptide. Purified N-terminal peptide prepared from 
phosphorylated vimentin was digested with cyanogen bromide 
and the peptides separated by reversed-phase HPLC on a CS 
column. The flow rate was 1 ml/min and 0.5 ml fractions were 
collected. 
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Fig.5. SDS gel analysis of cyanogen bromide phosphopeptides 
derived from the 12 kDa N-terminal region. Autoradiograph of 
HPLC purified cyanogen bromide peptides CNBr 1 (lane 1) and 
CNBr 2 (lane 2). The positions of protein standards (in kDa) are 
indicated. 
the N-terminal region of vimentin filaments can 
dramatically affect filament subunit interactions 
under in vitro conditions. 
Examination of the amino acid sequence of 
hamster vimentin indicates that it is not surprising 
that this domain of the molecule is phosphorylated 
by CAMP-dependent kinase. The N-terminal do- 
main is a positively charged, serine rich region 
[13,40]. It contains 7 sites with serines located 
within one or two positions on the C-terminal side 
of arginine residues, Arg-X-Ser or Arg-X-X-Ser, a 
characteristic feature of certain other substrates 
for CAMP-dependent kinase [42]. 
In intact cells, there are temporal associations 
between changes in filament phosphorylation and 
alterations in filament organization. When cells 
undergo mitosis, there is a dramatic reorganization 
of intermediate filaments that is associated with in- 
creased subunit phosphorylation [4,6-9,411. The 
kinase or kinases that are involved in this process 
have not yet been characterized, but the mitosis- 
specific increase in phosphorylation of vimentin 
also involves serine sites within the 12 kDa N- 
terminal fragment [39]. 
While there is accumulating indirect evidence 
that phosphorylation can affect intermediate fila- 
ment organization, a direct extrapolation of in 
vitro assembly/disassembly studies must be viewed 
with some caution. In particular, Soellner et al. 
[43] have reported that the small soluble pool of 
vimentin in cells is not more highly phosphorylated 
than filamentous vimentin. In addition, the in- 
creased phosphorylation of vimentin in mitotic 
cells does not appear to result in a highly 
phosphorylated soluble form of the molecule [6,7]. 
More likely, phosphorylation induced filament 
disassembly is an indication of the importance of 
the N-terminal ‘head’ domain on modifying fila- 
ment subunit interactions and a reflection of a 
more subtle mechanism in living cells. 
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